Charles Winter

Charles Winter

Chief Technical OfficeratJanux Therapeutics· In proxies 2022–2023

Pay in FY2023+4% from the year before · Janux Therapeutics stock -18.5% the same year

Charles Winter was paid $1.6M in FY2023 (Dec), up 4%. Janux Therapeutics stock fell 18.5% that year.

Pay$100 in the stock at the end of FY21 → $54
Pay is from the Summary Compensation Table of each Janux Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Janux TherapeuticsPublic company · 4 yr
    • Chief Technical Officer2022 – Present · 4 yrStock in role -11%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?